France· FR:68862107
GEFITINIB ACCORD 250 mg, comprimé pelliculé
A medicinal product containing géfitinib, registered in France by ACCORD HEALTHCARE FRANCE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- GÉFITINIB
- Manufacturer
- ACCORD HEALTHCARE FRANCE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340093016832530 plaquette(s) PVC PVDC aluminium prédécoupées unitaires de 1 comprimé(s)EUR 754.65
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Géfitinib in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainGEFITINIB ACCORD 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAccord Healthcare S.L.U.
- NetherlandsGefitinib Eugia 250 mg filmomhulde tablettenEugia Pharma (Malta) Limited
- FinlandGefitinib AccordAccord Healthcare B.V.
- BelgiumGefitinib Accord 250 mgAccord Healthcare
- PolandGefitinib AccordAccord Healthcare Polska Sp. z o.o.
- SwedenGefitinib Accord 250 mg Filmdragerad tablettAccord Healthcare B.V.
- United StatesGefitinibNatco Pharma USA LLC
- IcelandGefitinib STADASTADA Arzneimittel AG
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Gefitinib Accord
- Belgium · Gefitinib Accord, Gefitinib Sandoz
- Bulgaria · Фромпо
- Cyprus · Refetib
- Czechia · Gefitinib Accord
- Germany · Gefitinib Accord, Gefitinib Genthon
- Denmark · Gefitinib Accord, Gefitinib Stada
- Estonia · Gefitinib Auxilia, Gefitinib Norameda
- Spain · Gefitinib Efg Genthon, Gefitinib Eugia
- Finland · Gefitinib Accord, Gefitinib Stada
- United Kingdom (Northern Ireland) · Gefitinib Accord, Gefitinib Eugia (Uk)
- Greece · Gefitinib Faran, Gefitinib Genepharm
- Croatia · Gefitinib Pliva, Gefitinib Sandoz
- Hungary · Gefitinib Genepharm, Gefitinib Onkogen
- Iceland · Gefitinib Stada, Gefitinib Wh
- Italy · Gefitinib Medac
- Liechtenstein · Iressa
- Lithuania · Gefitinib Norameda
- Latvia · Gefitinib Norameda
- Malta · Gefitinib Eugia, Gefitinib Genthon
- Netherlands · Gefitinib Eugia, Gefitinib Genthon
- Norway · Gefitinib Stada, Iressa
- Poland · Gefitinib Accord, Gefitinib Genthon
- Portugal · Gefitinib Accord, Gefitinib Eugia
- Romania · Gefitinib Accord, Gefitinib Polisano
- Sweden · Gefitinib Accord, Gefitinib Stada
- Slovenia · Phrompo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e4a9d3d3-e57e-478a-bb0b-77373416a368 GET /v1/drugs/e4a9d3d3-e57e-478a-bb0b-77373416a368?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "68862107",
"date_amm": "2018-12-19",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "GÉFITINIB",
"statut_amm": "Autorisation archivée",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about géfitinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.